MAZE
Financials
- Market Capitalization 1.65 B
- Employee 141
- Founded 2017
- CEO N/A
- Website www.mazetx.com
- Headquarter Delaware, United States
- FIGI BBG00NHJHS27
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1990 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 40.70 USD | -1.83% | +1.17% | +5.88% | +55.40% | 1.95 B USD | ||
| 2056 |  GENB Generate Biomedicines, Inc. - Common Stock | 14.27 USD | +0.42% | -11.42% | +6.02% | -4.87% | 1.83 B USD | ||
| 2861 |  EIKN Eikon Therapeutics, Inc. - Common Stock | 10.25 USD | +0.59% | -11.26% | +7.78% | -39.88% | 554.92 M USD | ||
| 3046 |  CBIO Crescent Biopharma, Inc. - Common Stock | 15.31 USD | 0.00% | -9.78% | -15.65% | +29.64% | 422.13 M USD |
Frequently asked questions about Maze Therapeutics, Inc. - Common Stock
What is the Maze Therapeutics, Inc. - Common Stock stock price today?
The current price of Maze Therapeutics, Inc. - Common Stock (MAZE) is 29.88. Over the past 24 hours, the stock has changed by +2.40%. Follow the MAZE chart for real-time price dynamics.
What is the stock ticker of Maze Therapeutics, Inc. - Common Stock?
Maze Therapeutics, Inc. - Common Stock trades under the ticker MAZE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Maze Therapeutics, Inc. - Common Stock stock going up?
MAZE has changed by -9.01% over the last week, +23.68% over the last month, and -33.64% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Maze Therapeutics, Inc. - Common Stock net income for the last quarter?
Maze Therapeutics, Inc. - Common Stock reported net income of -24.21 M for the last quarter. The previous quarter showed -34.57 M, which means net income changed by +29.97%.
How many employees does Maze Therapeutics, Inc. - Common Stock have?
As of the latest available data, Maze Therapeutics, Inc. - Common Stock has 141 employees. Workforce size can provide additional context about the company's scale and operations.
What is Maze Therapeutics, Inc. - Common Stock EBITDA?
Maze Therapeutics, Inc. - Common Stock EBITDA is -27.53 M, and its EBITDA margin is -137.66%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Maze Therapeutics, Inc. - Common Stock stock?
You can buy Maze Therapeutics, Inc. - Common Stock (MAZE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Maze Therapeutics, Inc. - Common Stock stock?
Investing in Maze Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MAZE chart and related analysis on metatrader.com as part of your research.